Yosef Y Tobi

8PUBLICATIONS
15CO-AUTHORS
Sensory processes, perception and performancePredictive and prognostic markersCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 29, 2025
Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia/Chronic Fatigue Syndrome (ME/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles.

Martin Tobi, Diptaraj Chaudhari, Elizabeth P Ryan

|Mar 28, 2025
Historic p87 Is Diagnostic for Lung Cancer Preceding Clinical Presentation by at Least 4 Years.

Martin Tobi, Daniel Ezekwudo, Yosef Y Tobi

|Nov 07, 2024
The Innate Immune System Surveillance Biomarker p87 in African Americans and Caucasians with Small High-Grade Dysplastic Adenoma [SHiGDA] and Right-Sided JAK3 Colon Mutations May Explain the Presence of Multiple Cancers Revealing an Important Minority of Patients with JAK3 Mutations and Colorectal Neoplasia.

Martin Tobi, Xiaoqing Zhao, Rebecca Rodriquez

|Dec 23, 2023
The Non-Invasive Prediction of Colorectal Neoplasia (NIPCON) Study 1995-2022: A Comparison of Guaiac-Based Fecal Occult Blood Test (FOBT) and an Anti-Adenoma Antibody, Adnab-9.

Martin Tobi, Fadi Antaki, Mary Ann Rambus

|Apr 28, 2023
In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective Population Database?

Martin Tobi, Martin H Bluth, Noreen F Rossi

|Sep 23, 2022
Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer.

Kamrine E Poels, Adam J Schoenfeld, Alex Makhnin

Pageof 2

Frequent Collaborators

5 joint publications

Benita McVicker

2 joint publications

Kamrine E Poels

2 joint publications

Franziska Michor

1 joint publications

Diptaraj Chaudhari